Related references
Note: Only part of the references are listed.Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs
Elaine H. Morrato et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder
Melissa P. DelBello et al.
BIPOLAR DISORDERS (2009)
Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study
Magali Haas et al.
BIPOLAR DISORDERS (2009)
Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: double-blind study
Magali Haas et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Depressive Symptoms and the Metabolic Syndrome in Childhood and Adulthood: A Prospective Cohort Study
Laura Pulkki-Raback et al.
HEALTH PSYCHOLOGY (2009)
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
Christoph U. Correll et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia
Magali Haas et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2009)
Aripiprazole in Children and Adolescents With Bipolar Disorder Comorbid With Attention-Deficit/Hyperactivity Disorder: A Pilot Randomized Clinical Trial
Silza Tramontina et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Acute Treatment of Pediatric Bipolar I Disorder, Manic or Mixed Episode, With Aripiprazole: A Randomized, Double-Blind, Placebo-Controlled Study
Robert L. Findling et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder
Ronald N. Marcus et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2009)
Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial
Ludmila Kryzhanovskaya et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2009)
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Randall Owen et al.
PEDIATRICS (2009)
Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizoaffective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
Linmarie Sikich et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Childhood predictors of the metabolic syndrome in adulthood. The Cardiovascular Risk in Young Finns Study
Noora Mattsson et al.
ANNALS OF MEDICINE (2008)
Clozapine and high-dose olanzapine in refractory early-onset schizophrenia: A 12-week randomized and double-blind comparison
Sanjiv Kumra et al.
BIOLOGICAL PSYCHIATRY (2008)
Extrapyramidal side-effects of antipsychotics in a randomised trial
Del D. Miller et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder
Daniel F. Connor et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2008)
Risperidone versus haloperidol in children and adolescents with AD - A randomized, controlled, double-blind trial
Suha Miral et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2008)
Olanzapine versus placebo in the treatment of adolescents with bipolar mania
Mauricio Tohen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: A placebo-controlled pilot study
Jorge L. Armenteros et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)
Age onset subtypes of obsessive compulsive disorder:: Differences in clinical response to treatment with clomipramine
Rosa-Elena Ulloa et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2007)
Risperidone in preschool children with autistic spectrum disorders: An investigation of safety and efficacy
Joan Luby et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder
Eric Hollander et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)
Childhood-onset schizophrenia - A double-blind, randomized clozapine-olanzapine comparison
Philip Shaw et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
National trends in the outpatient treatment of children and adolescents with antipsychotic drugs
Mark Olfson et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents with disruptive behavior disorders
M Reyes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania
MP Delbello et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2006)
Risk factors identified in childhood and decreased carotid artery elasticity in adulthood -: The cardiovascular risk in Young Finns Study
M Juonala et al.
CIRCULATION (2005)
Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial
DL Gilbert et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2004)
Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients
S Janno et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: A double-blind, randomized, 8-week trial
L Sikich et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders
S Shea et al.
PEDIATRICS (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Effects of development on olanzapine-associated adverse events
SW Woods et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania
MP DelBello et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs
R Snyder et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
Trends in antipsychotic use in a Texas Medicaid population of children and adolescents: 1996 to 2000
NC Patel et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2002)
Risperidone in children with autism and serious behavioral problems
JT McCracken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence
MG Aman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome
GR Gaffney et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2002)
A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities
JK Buitelaar et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: A double-blind, placebo-controlled pilot trial
M Van Bellinghen et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2001)
A double-blind pilot study of risperidone in the treatment of conduct disorder
RL Findling et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2000)
Ziprasidone treatment of children and adolescents with Tourette's syndrome: A pilot study
FR Sallee et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2000)
Share Paper
